# Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis

> **NCT05743946** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 32 (actual)

## Conditions studied

- Non-cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** Trikafta

## Key facts

- **NCT ID:** NCT05743946
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-18
- **Primary completion:** 2025-12-23
- **Final completion:** 2025-12-23
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05743946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05743946, "Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05743946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*